Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Minasian

Showing results (131-140 of 174) with videos related to

Pageof 18
Sort By:
Journal of the National Cancer Institute|February 25, 2014
Baseline selenium status and effects of selenium and vitamin e supplementation on prostate cancer riskAlan R Kristal, Amy K Darke, J Steven Morris, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 10, 2023
Reliability and validity of PRO-CTCAE® daily reporting with a 24-hour recall periodM K Lee, E Basch, S A Mitchell, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 16, 2014
Plasma vitamin D and prostate cancer risk: results from the Selenium and Vitamin E Cancer Prevention TrialAlan R Kristal, Cathee Till, Xiaoling Song, et al.
Respiratory Research|April 19, 2015
A randomized controlled trial of vitamin E and selenium on rate of decline in lung functionPatricia A Cassano, Kristin A Guertin, Alan R Kristal, et al.
Clinical Trials (London, England)|October 16, 2012
Moving a randomized clinical trial into an observational cohortPhyllis J Goodman, Jo Ann Hartline, Catherine M Tangen, et al.
Journal of the National Cancer Institute|July 10, 2014
Recommended patient-reported core set of symptoms to measure in adult cancer treatment trialsBryce B Reeve, Sandra A Mitchell, Amylou C Dueck, et al.
Journal of the National Cancer Institute|January 24, 2018
Two-Year Trends of Taxane-Induced Neuropathy in Women Enrolled in a Randomized Trial of Acetyl-L-Carnitine (SWOG S0715)Dawn L Hershman, Joseph M Unger, Katherine D Crew, et al.
Journal of the American Medical Informatics Association : JAMIA|March 7, 2019
Patient free text reporting of symptomatic adverse events in cancer clinical research using the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)Arlene E Chung, Kimberly Shoenbill, Sandra A Mitchell, et al.
Trials|August 14, 2016
Opportunities and challenges in incorporating ancillary studies into a cancer prevention randomized clinical trialPhyllis J Goodman, Catherine M Tangen, Amy K Darke, et al.
Clinical Trials (London, England)|October 23, 2024
Statistical properties of items and summary scores from the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE<sup>®</sup>) in a diverse cancer sampleCarolyn Mead-Harvey, Ethan Basch, Lauren J Rogak, et al.
Pageof 18

Showing results (131-140 of 174) with videos related to

Sort By:
Pageof 18
Journal of the National Cancer Institute|February 25, 2014
Baseline selenium status and effects of selenium and vitamin e supplementation on prostate cancer riskAlan R Kristal, Amy K Darke, J Steven Morris, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 10, 2023
Reliability and validity of PRO-CTCAE® daily reporting with a 24-hour recall periodM K Lee, E Basch, S A Mitchell, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 16, 2014
Plasma vitamin D and prostate cancer risk: results from the Selenium and Vitamin E Cancer Prevention TrialAlan R Kristal, Cathee Till, Xiaoling Song, et al.
Respiratory Research|April 19, 2015
A randomized controlled trial of vitamin E and selenium on rate of decline in lung functionPatricia A Cassano, Kristin A Guertin, Alan R Kristal, et al.
Clinical Trials (London, England)|October 16, 2012
Moving a randomized clinical trial into an observational cohortPhyllis J Goodman, Jo Ann Hartline, Catherine M Tangen, et al.
Journal of the National Cancer Institute|July 10, 2014
Recommended patient-reported core set of symptoms to measure in adult cancer treatment trialsBryce B Reeve, Sandra A Mitchell, Amylou C Dueck, et al.
Journal of the National Cancer Institute|January 24, 2018
Two-Year Trends of Taxane-Induced Neuropathy in Women Enrolled in a Randomized Trial of Acetyl-L-Carnitine (SWOG S0715)Dawn L Hershman, Joseph M Unger, Katherine D Crew, et al.
Journal of the American Medical Informatics Association : JAMIA|March 7, 2019
Patient free text reporting of symptomatic adverse events in cancer clinical research using the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)Arlene E Chung, Kimberly Shoenbill, Sandra A Mitchell, et al.
Trials|August 14, 2016
Opportunities and challenges in incorporating ancillary studies into a cancer prevention randomized clinical trialPhyllis J Goodman, Catherine M Tangen, Amy K Darke, et al.
Clinical Trials (London, England)|October 23, 2024
Statistical properties of items and summary scores from the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE<sup>®</sup>) in a diverse cancer sampleCarolyn Mead-Harvey, Ethan Basch, Lauren J Rogak, et al.
Pageof 18